In use product safety assessment report for trastuzumab

David Erskine, Director, London Medicines Information Services, Specialist Pharmacy ServicePublished

A UKMi Product Safety assessment on  trastuzumab products (including the biosimilars) which describes the in-use medication safety considerations resultant from the product’s presentation or other pre-defined characteristics. Potential next steps and mitigation actions are suggested.

 

Attachments